Relationship between paraoxonase-1 activity, its Q192R genetic variant and clopidogrel responsiveness in the ADRIE study

被引:46
作者
Fontana, P. [1 ]
James, R. [2 ]
Barazer, I. [4 ]
Berdague, P. [5 ]
Schved, J. -F. [6 ]
Rebsamen, M. [7 ]
Vuilleumier, N. [7 ]
Reny, J. -L. [3 ,8 ]
机构
[1] Univ Hosp Geneva, Div Angiol & Hemostasis, CH-1211 Geneva 14, Switzerland
[2] Univ Hosp Geneva, Dept Med Specialties, Div Endocrinol Diabetol & Nutr, CH-1211 Geneva 14, Switzerland
[3] Fac Med, Geneva, Switzerland
[4] Beziers Hosp, Hematol Lab, Beziers, France
[5] Beziers Hosp, Div Cardiol, Beziers, France
[6] Montpellier Univ Hosp, Hematol Lab, Montpellier, France
[7] Univ Hosp Geneva, Dept Genet & Lab Med, Div Lab Med, CH-1211 Geneva 14, Switzerland
[8] Univ Hosp Geneva, Div Gen Internal Med, CH-1211 Geneva 14, Switzerland
关键词
OF-FUNCTION POLYMORPHISM; PLATELET-FUNCTION; MAJOR DETERMINANT; METABOLITE; ASPIRIN; CYP2C19; PLASMA;
D O I
10.1111/j.1538-7836.2011.04409.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1664 / 1666
页数:3
相关论文
共 17 条
[1]   Acute Coronary Syndrome and its Antithrombotic Treatment: Focus on Aspirin and Clopidogrel Resistance [J].
Bonvini, Robert F. ;
Reny, Jean-Luc ;
Mach, Francois ;
Zeller, Thomas ;
Fontana, Pierre .
CURRENT VASCULAR PHARMACOLOGY, 2009, 7 (02) :198-208
[2]   Which platelet function test is suitable to monitor clopidogrel responsiveness? A pharmacokinetic analysis on the active metabolite of clopidogrel [J].
Bouman, H. J. ;
Parlak, E. ;
van Werkum, J. W. ;
Breet, N. J. ;
ten Cate, H. ;
Hackeng, C. M. ;
ten Berg, J. M. ;
Taubert, D. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (03) :482-488
[3]   Paraoxonase-1 is a major determinant of clopidogrel efficacy [J].
Bouman, Heleen J. ;
Schoemig, Edgar ;
van Werkum, Jochem W. ;
Velder, Janna ;
Hackeng, Christian M. ;
Hirschhaeuser, Christoph ;
Waldmann, Christopher ;
Schmalz, Hans-Guenther ;
ten Berg, Jurrien M. ;
Taubert, Dirk .
NATURE MEDICINE, 2011, 17 (01) :110-U287
[4]  
Camps J, 2011, NAT MED IN PRESS
[5]   Resistance to antiplatelet drugs: molecular mechanisms and laboratory detection [J].
Cattaneo, M. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 :230-237
[6]   Clinical implications of clopidogrel non-response in cardiovascular patients: a systematic review and meta-analysis [J].
Combescure, C. ;
Fontana, P. ;
Mallouk, N. ;
Berdague, P. ;
Labruyere, C. ;
Barazer, I. ;
Gris, J. C. ;
Laporte, S. ;
Fabbro-Peray, P. ;
Reny, J. L. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (05) :923-933
[7]   Is there really a relationship between the plasma concentration of the active metabolite of clopidogrel and the results of platelet function tests? [J].
Delavenne, X. ;
Mallouk, N. ;
Piot, M. ;
Mismetti, P. ;
Laporte, S. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (10) :2334-2338
[8]   Influence of CYP2C19 and CYP3A4 gene polymorphisms on clopidogrel responsiveness in healthy subjects [J].
Fontana, P. ;
Hulot, J.-S. ;
De Moerloose, P. ;
Gaussem, P. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (10) :2153-2155
[9]   Clinical predictors of dual aspirin and clopidogrel poor responsiveness in stable cardiovascular patients from the ADRIE study [J].
Fontana, P. ;
Berdague, P. ;
Castelli, C. ;
Nolli, S. ;
Barazer, I. ;
Fabbro-Peray, P. ;
Schved, J. -F. ;
Bounameaux, H. ;
Mach, F. ;
de Moerloose, P. ;
Reny, J. -L. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (12) :2614-2623
[10]   Impact of Cytochrome P450 2C19 Loss-of-Function Polymorphism and of Major Demographic Characteristics on Residual Platelet Function After Loading and Maintenance Treatment With Clopidogrel in Patients Undergoing Elective Coronary Stent Placement [J].
Hochholzer, Willibald ;
Trenk, Dietmar ;
Fromm, Martin F. ;
Valina, Christian M. ;
Stratz, Christian ;
Bestehorn, Hans-Peter ;
Buettner, Heinz Joachim ;
Neumann, Franz-Josef .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (22) :2427-2434